Ignite Creation Date:
2024-05-06 @ 6:35 PM
Last Modification Date:
2024-10-26 @ 2:50 PM
Study NCT ID:
NCT05713318
Status:
COMPLETED
Last Update Posted:
2023-05-16
First Post:
2023-01-31
Brief Title:
A Study To Assess The Efficacy and Safety of HH-120 Nasal Spray for the Treatment of Mild COVID-19
Sponsor:
Huahui Health
Organization:
Huahui Health
Study Overview
Official Title:
A Multicenter Randomized Double-Blind Placebo-Controlled Phase 2 Study to Assess the Efficacy and Safety of HH-120 Nasal Spray for the Treatment of Mild COVID-19
Status:
COMPLETED
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a randomized double-blind placebo-controlled Phase 2 study in participants over the age of 18 years with mild COVID-19 The main purpose of this study is to evaluate the effect on viral load clearance and clinical recovery and safety of HH-120 nasal spray in participants over the age of 18 years with mild COVID-19 according to the FDA definition 2021
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None